Literature DB >> 10694893

Lp85 calpain is an enzymatically active rodent-specific isozyme of lens Lp82.

H Ma1, M Shih, I Hata, C Fukiage, M Azuma, T R Shearer.   

Abstract

PURPOSES: To clone and sequence the cDNA for Lp85 calpain from young rat lens, and to test for Lp85 protein expression and proteolytic activity.
METHODS: RT-PCR and molecular cloning were performed on total RNA from 12 day-old rats. Lp85 protein expression was visualized by immunoblotting using a specific antibody developed to the unique peptide sequence in Lp85. Proteolytic activity was assessed by casein zymography. Transient expression of Lp85 and previously characterized lens-specific calpain Lp82 were separately performed in mammalian COS-7 cells.
RESULTS: The 2410-bp cDNA for rat lens Lp85 encoded a protein of 737 amino acid residues with a calculated molecular weight of 85.0 kDa and a predicted pI of 5.67. The amino acid sequence of Lp85 was identical to Lp82 except for an insert region of 28 amino acids in domain IV of the calcium-binding region. mRNA and protein for Lp85 were present only in rat and mouse lenses and not in other tissues or species. Lp85 protein concentrations were highest in the nuclear region, most concentrated in the insoluble fraction, disappeared with lens maturation, and Lp85 exhibited migration similar to Lp82 on native PAGE gels. Lp85 was enzymatically active when expressed in COS-7 cells.
CONCLUSIONS: Lp85 is a newly classified, lens- and rodent-specific, enzymatically active, member of the AX1 (alternative exon 1) subclass of calpains. In conjunction with Lp82 and m-calpain in lens, Lp85 may be responsible for proteolysis during normal lens development and maturation or during cataract formation in young rodents.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694893

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.

Authors:  L Blázquez; M Azpitarte; A Sáenz; M Goicoechea; D Otaegui; X Ferrer; I Illa; E Gutierrez-Rivas; J J Vilchez; A López de Munain
Journal:  Neurogenetics       Date:  2008-06-19       Impact factor: 2.660

2.  Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle.

Authors:  Sante Roperto; Roberta De Tullio; Cinzia Raso; Roberto Stifanese; Valeria Russo; Marco Gaspari; Giuseppe Borzacchiello; Monica Averna; Orlando Paciello; Gianni Cuda; Franco Roperto
Journal:  PLoS One       Date:  2010-04-22       Impact factor: 3.240

Review 3.  Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review.

Authors:  Suman Biswas; Frederick Harris; Jaipaul Singh; David Phoenix
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

4.  MALDI tissue profiling of integral membrane proteins from ocular tissues.

Authors:  Danielle B Thibault; Christopher J Gillam; Angus C Grey; Jun Han; Kevin L Schey
Journal:  J Am Soc Mass Spectrom       Date:  2008-03-18       Impact factor: 3.109

5.  Calpain-3 impairs cell proliferation and stimulates oxidative stress-mediated cell death in melanoma cells.

Authors:  Daniele Moretti; Barbara Del Bello; Giulia Allavena; Alessandro Corti; Cinzia Signorini; Emilia Maellaro
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 6.  CAPN3: A muscle‑specific calpain with an important role in the pathogenesis of diseases (Review).

Authors:  Lin Chen; Fajuan Tang; Hu Gao; Xiaoyan Zhang; Xihong Li; Dongqiong Xiao
Journal:  Int J Mol Med       Date:  2021-09-22       Impact factor: 4.101

7.  The function of filensin and phakinin in lens transparency.

Authors:  Mikako Oka; Hiroaki Kudo; Norio Sugama; Yuko Asami; Makoto Takehana
Journal:  Mol Vis       Date:  2008-04-25       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.